Pavla Brachova

TP53 oncomorphic mutations predict resistance to platinum- and taxane-based standard chemotherapy in patients diagnosed with advanced serous ovarian carcinoma

Pavla Brachova, Samuel R. Mueting, Matthew J. Carlson et al. · International Journal of Oncology · 2014 · 95 citations · Full text

Cytoplasmic Metadherin (MTDH) Provides Survival Advantage under Conditions of Stress by Acting as RNA-binding Protein

Xiangbing Meng, Danlin Zhu, Shujie Yang et al. · Journal of Biological Chemistry · 2011 · 58 citations · Full text

Knockdown of MTDH Sensitizes Endometrial Cancer Cells to Cell Death Induction by Death Receptor Ligand TRAIL and HDAC Inhibitor LBH589 Co-Treatment

Xiangbing Meng, Pavla Brachova, Shujie Yang et al. · PLoS ONE · 2011 · 54 citations · Full text

Apoptosis, Gynecology, Cell Death +16

Induction of mitotic cell death by overriding G2/M checkpoint in endometrial cancer cells with non-functional p53

Xiangbing Meng, Laura L. Laidler, Elizabeth A. Kosmacek et al. · Gynecologic Oncology · 2012 · 36 citations · Full text

Mitotic Cell Death, Medicine, Apoptosis +8

Oncomorphic <i>TP</i>53 Mutations in Gynecologic Cancers Lose the Normal Protein:Protein Interactions with the microRNA Microprocessing Complex

Pavla Brachova, Samuel R. Mueting, Eric J. Devor et al. · Journal of Cancer Therapy · 2014 · 16 citations · Full text